JPRN-UMIN000010461已完成未知
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathy - Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathy
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Lesion size >=12 disc area (1 disc rea is 30.5mm2). 'Lesion' includes hemorrhage, scar, and CNV. 2) Area of subretinal hemorrage in study eye>=50% of total lesion area 3) Area of scar or fibrosis in study eye>=50% of total lesion area 4) RPE tear in study eye 5) Stage 3 or 4 macular hole in study eye 6) Administration of triamcinolone to study eye within 6 months prior to this study 7) Administration of dexamethasone to study eye within 30 days prior to this study 8) Intraocular surgery to study eye within 6 months prior to this study 9) Any history of vitrectomy in study eye 10) Any inflammation or infection in intra-or extra-ocular tissue in either eye 11) History of uveitis in either eye 12) Allergy to fluorescein, indocyanine or iodine 13) pregnant women and nursing mothers 14) Patients who were judged by docters to be inappropriate for this study
研究者
相似试验
已完成
3 期
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
已完成
4 期
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
进行中（未招募）
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
进行中（未招募）
不适用
Optical Coherence Tomography Angiography Biomarkers in a Bi-monthly Maintenance Dosing Aflibercept in Patients with Neovascular Age-Related Macular DegeneratioDiseases of the eye and adnexaKCT0007375Kyung Hee University Hospital40